OncoC4
- Biotech or pharma, therapeutic R&D
Our pipeline is based on the pioneering scientific discoveries in immune checkpoints include CD24, Siglec, and CTLA-4. We look forward to working with partners and investors to accelerate the development of these first-in-class and best-in-class programs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}